BIOMAT Database Logo BIOMAT Database Logo

Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. 1995

R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

A lead compound obtained from a high volume human non-pancreatic secretory phospholipase A2 (hnps-PLA2) screen has been developed into a potent inhibitor using detailed structural knowledge of inhibitor binding to the enzyme active site. Four crystal structures of hnps-PLA2 complexed with a series of increasingly potent indole inhibitors were determined and used as the structural basis for both understanding this binding and providing valuable insights for further development. The application of structure-based drug design has made possible improvements in the binding of this screening lead to the enzyme by nearly three orders of magnitude. Furthermore, the optimized structure (LY311727) displayed 1,500-fold selectivity when assayed against porcine pancreatic s-PLA2.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D011189 Potassium Chloride A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. Slow-K,Chloride, Potassium
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea

Related Publications

R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Indole-5-phenylcarbamate derivatives as human non-pancreatic secretory phospholipase A2 inhibitor.
October 2005, Bioorganic & medicinal chemistry letters,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.
April 1998, Journal of biochemistry,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Structure and properties of a human non-pancreatic phospholipase A2.
April 1989, The Journal of biological chemistry,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolism.
November 1997, Journal of lipid research,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis.
May 2005, International immunopharmacology,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors.
July 1996, European journal of pharmacology,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
[Structure and function of mammalian non-pancreatic phospholipase A2].
February 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Tailoring the pH dependence of human non-pancreatic secretory phospholipase A2 by engineering surface charges.
November 2013, Applied biochemistry and biotechnology,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
[Mammalian non-pancreatic phospholipase A2: structure, characterization, and function].
November 1992, Seikagaku. The Journal of Japanese Biochemical Society,
R W Schevitz, and N J Bach, and D G Carlson, and N Y Chirgadze, and D K Clawson, and R D Dillard, and S E Draheim, and L W Hartley, and N D Jones, and E D Mihelich
Design and synthesis of new secretory phospholipase A2 inhibitor of a phospholipid analog.
December 1998, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!